Artwork for podcast The LDN Radio Show About Low Dose Naltrexone
Autoimmune thyroiditis Part 1 by Kent Holtorf, MD
Episode 4014th December 2022 • The LDN Radio Show About Low Dose Naltrexone • Linda Elsegood
00:00:00 01:02:44

Share Episode


Kent Holtorf, MD, is the medical director of the Holtorf Medical Group( and founder and medical director of the non-profit National Academy of Hypothyroidism ( He is also the founder of Integrative Peptides (, dedicated to training physicians about ground-breaking peptide therapies and bringing doctors and patients the highest quality natural bioidentical peptides as supplements with unique delivery systems.

Dr. Holtorf is an internationally known lecturer, author, and innovator in cutting-edge research and treatments. He has personally trained numerous physicians across the country in the use of bioidentical hormones, thyroid replacement for complex hypothyroidism syndromes, peptide therapies, immune-modulatory strategies, stem cell, exosome and growth factor treatment, hormone replacement for complex endocrine dysfunction, and innovative treatments of chronic fatigue syndrome, fibromyalgia, Lyme disease, and other chronic infectious diseases, CIRS, neurodegenerative diseases, and many others.

He is a fellowship lecturer for A4M. He was the Endocrinology Expert for AOL Health and is a guest editor and peer-reviewer for the medical journals Endocrine, Postgraduate Medicine, and Pharmacy Practice. Dr. Holtorf has published many peer-reviewed endocrine reviews on complex, multisystem, poorly understood conditions. He has demonstrated that much of the long-held dogma in endocrinology and infectious disease is inaccurate.

He has been a featured guest on CNBC, ABC News, CNN, Fox News (debated the Fox news medical A-team), Good Morning America, The Today Show, EXTRA TV, Discovery Health, The Learning Channel, Glenn Beck, Nancy Grace, Sean Hannity, and more and quoted in numerous print media including the Wall Street Journal, Los Angeles Times, US News and World Report, San Francisco Chronicle, WebMD, Forbes, among many others.